Page 1 | Search Results | Hematology, ASH Education Program

1-10 of 10

Sort by

Sort Order Select

Journal Articles

What we have learned about direct oral anticoagulant reversal

Deborah M. Siegal

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 198–203.

https://doi.org/10.1182/hematology.2019000072

Published: 2019

Journal Articles

Evidence-Based Minireview: Mortality and thrombosis in patients receiving prothrombin complex concentrates or andexanet alfa for the management of direct oral factor Xa inhibitor–associated major bleeding

Miriam Kimpton, Deborah M. Siegal

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 204–208.

https://doi.org/10.1182/hematology.2019000074

Published: 2019

Journal Articles

Monitoring and reversal of direct oral anticoagulants

Adam Cuker, Deborah Siegal

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 117–124.

https://doi.org/10.1182/asheducation.V2015.1.117.3916182

Published: 2015

Journal Articles

Plasma versus prothrombin complex concentrate for warfarin-associated major bleeding: a systematic review

Deborah M. Siegal, William J. Savage

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 448–453.

https://doi.org/10.1182/asheducation-2015.1.448

Published: 2015

Journal Articles

Coagulopathy in liver disease: a balancing act

Jody L. Kujovich

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 243–249.

https://doi.org/10.1182/asheducation-2015.1.243

Published: 2015

Journal Articles

Reversing targeted oral anticoagulants

Maureane Hoffman, Dougald M. Monroe

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 518–523.

https://doi.org/10.1182/asheducation-2014.1.518

Published: 2014

Journal Articles

The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders

Margaret V. Ragni

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 44–51.

https://doi.org/10.1182/asheducation-2013.1.44

Published: 2013

Journal Articles

The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question

Lisa K. Hicks, Harriet Bering, Kenneth R. Carson, Judith Kleinerman, Vishal Kukreti, Alice Ma, Brigitta U. Mueller, Sarah H. O'Brien, Marcelo Pasquini, Ravindra Sarode, Lawrence Solberg, Jr, Adam E. Haynes, Mark A. Crowther

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 9–14.

https://doi.org/10.1182/asheducation-2013.1.9

Published: 2013

Journal Articles

Therapeutic challenges in acquired factor VIII deficiency

Peter W. Collins

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 369–374.

https://doi.org/10.1182/asheducation.V2012.1.369.3798356

Published: 2012

Journal Articles

Management of Excessive Anticoagulant Effect Due to Vitamin K Antagonists

Francesco Dentali, Mark A. Crowther

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 266–270.

https://doi.org/10.1182/asheducation-2008.1.266

Published: 2008

NARROW

What we have learned about direct oral anticoagulant reversal

Evidence-Based Minireview: Mortality and thrombosis in patients receiving prothrombin complex concentrates or andexanet alfa for the management of direct oral factor Xa inhibitor–associated major bleeding

Monitoring and reversal of direct oral anticoagulants

Plasma versus prothrombin complex concentrate for warfarin-associated major bleeding: a systematic review

Coagulopathy in liver disease: a balancing act

Reversing targeted oral anticoagulants

The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders

The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question

Therapeutic challenges in acquired factor VIII deficiency

Management of Excessive Anticoagulant Effect Due to Vitamin K Antagonists

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only